There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apellis Pharmaceuticals (APLS – Research Report) ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

Wall Street trading got off to a mixed start on Thursday following earnings from AI-darling Nvidia overnight and an update ...

Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...

A GOP budget plan that requires deep cuts to Medicaid spending battered shares of health insurers and hospitals that do big business in the government funded health program. Shares of Centene, t ...

Operating income fell for all but two major payers’ insurance divisions in the fourth quarter. And 2025 may be no better, ...

Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.